KalVista Pharmaceuticals, Inc. (FRA:4XC1)
Germany · Delayed Price · Currency is EUR 11.90
-0.10 (-0.83%)
At close: Dec 1, 2025
KalVista Pharmaceuticals Market Cap
KalVista Pharmaceuticals has a market cap or net worth of €605.24 million as of December 1, 2025. Its market cap has increased by 22.29% in one year.
Market Cap
605.24M
Enterprise Value
582.38M
Revenue
1.25M
Ranking
n/a
PE Ratio
n/a
Stock Price
€11.90
Market Cap Chart
Since November 23, 2016, KalVista Pharmaceuticals's market cap has increased from 78.86M to 605.24M, an increase of 667.52%. That is a compound annual growth rate of 25.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 630.76M | 56.01% |
| Dec 31, 2024 | 404.30M | 5.56% |
| Dec 29, 2023 | 383.00M | 77.55% |
| Dec 30, 2022 | 215.71M | -24.22% |
| Dec 31, 2021 | 284.66M | 2.20% |
| Dec 31, 2020 | 278.54M | -1.59% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Nov 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.88B |
| Siemens Aktiengesellschaft | 176.79B |
| Allianz SE | 141.56B |
| Deutsche Telekom AG | 132.19B |
| Siemens Energy AG | 98.23B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.85B |
| Rheinmetall AG | 67.93B |
| Deutsche Bank Aktiengesellschaft | 58.37B |